Skip to content

Advertisement

  • RESEARCH
  • Open Access

Metabolic fate of pregnene-based steroids in the lactonization pathway of multifunctional strain Penicillium lanosocoeruleum

Microbial Cell Factories201817:100

https://doi.org/10.1186/s12934-018-0948-1

  • Received: 8 April 2018
  • Accepted: 16 June 2018
  • Published:

Abstract

Background

Metabolic activities of microorganisms to modify the chemical structures of organic compounds became an effective tool for the production of high-valued steroidal drugs or their precursors. Currently research efforts in production of steroids of pharmaceutical interest are focused on either optimization of existing processes or identification of novel potentially useful bioconversions. Previous studies demonstrated that P. lanosocoeruleum KCH 3012 metabolizes androstanes to the corresponding lactones with high yield. In order to explore more thoroughly the factors determining steroid metabolism by this organism, the current study was initiated to delineate the specificity of this fungus with respect to the cleavage of steroid side chain of progesterone and pregnenolone The effect of substituents at C-16 in 16-dehydropregnenolone, 16α,17α-epoxy-pregnenolone and 16α-methoxy-pregnenolone on the pattern of metabolic processing of these steroids was also investigated.

Results and discussion

All of the analogues tested (except the last of the listed) in multi-step transformations underwent the Baeyer–Villiger oxidation to their δ-d-lactones. The activity of 3β-HSD was a factor affecting the composition of the product mixtures. 16α,17α-epoxy-pregnenolone underwent a rare epoxide opening with retention stereochemistry to give four 16α-hydroxy-lactones. Apart from oxidative transformations, a reductive pathway was revealed with the unique hydrogenation of 5-ene double bond leading to the formation of 3β,16α-dihydroxy-17a-oxa-d-homo-5α-androstan-17-one. 16α-Methoxy-pregnenolone was transformed to the 20(R)-alcohol with no further conversion.

Conclusions

This work clearly demonstrated that P. lanosocoeruleum KCH 3012 has great multi-functional catalytic properties towards the pregnane-type steroids. Studies have highlighted that a slight modification of the d-ring of substrates may control metabolic fate either into the lactonization or reductive and oxidative pathways. Possibility of epoxide opening by enzymes from this microorganism affords a unique opportunity for generation of novel bioactive steroids.

Keywords

  • Steroid Baeyer–Villiger oxidation
  • Steroidal lactone
  • Biotransformation
  • Epoxide opening
  • Penicillium lanosocoeruleum
  • 16-dehydropregnenolone
  • 16α,17α-epoxypregnenolone

Background

Steroids are an important class of natural compounds, ubiquitous in nature and playing crucial functions for metabolism. Their physiological activity depends on the structure, primarily location and stereochemistry of the functional groups attached to the steroid nucleus. A variety of steroid compounds are widely used as anti-inflammatory, anti-allergic, immunosuppressive, anabolic, diuretic, progestational and contraceptive agents. They have also been used for the prevention of coronary heart disease, for the treatment of adrenal insufficiencies and some types of cancers [1]. Structural derivatization of naturally occurring steroid systems can modify their activity profile. Design of new, efficient methods of selective transformations of steroids is a serious challenge because of diverse, and often difficult to predict, reactivity of steroids, which usually are complex, multifunctional chemical species. Carrying out a series of stereospecific reactions occurring selectively is made possible by biotransformations [13]. The strongest impulse to use microbial transformations is due to an unusual diversity of enzymes produced by microbes and convenient process conditions. In recent years, Baeyer–Villiger oxidation (BVO) became object of growing interest considering the fact that the result of this reactions can provide steroids with anticancer and anti-androgenic properties.

BVO is an oxidation of ketones, in which cleavage of one of the C–CO–C bonds occurs with simultaneous insertion of an oxygen atom. The products of oxidation of acyclic ketones are esters, while cyclic ketones yield lactones. Oxidative factors employed for this reaction are most often hazardous peroxyacids or hydrogen peroxide. Toxicity and instability of these oxidizers, their explosive tendencies (particularly important in conjunction with flammable solvents in the industrial processes), and lack of selectivity, make chemical synthesis employing BVO seriously limited. In case the substrate is a compound containing other functions vulnerable to oxidation, an important issue is formation of byproducts (e.g. peroxyacids are able to oxidize also double bonds). The enzymes performing the BVO belong to the group of so-called Baeyer–Villiger monooxygenases (BVMOs). It is a class of oxidoreductases using atmospheric oxygen as a “green and free oxidant”. Steroidal BVMOs catalyze mainly oxidation of ketones bound to ring D, i.e. at C-17 and/or C-20 carbonyl groups. Although research on BVO of steroids has long history [4], the substrates of transformations were mostly 4-en-3-keto systems. Interest in this group of steroids was evoked by high antitumor and anti-androgen activity of testolactone (1-dehydrotestololactone). Testolactone as an inhibitor of steroid aromatase [5] is used in the treatment of advanced stages of breast cancer and some symptoms of premature puberty [6]. Steroidal lactones can inhibit activity of steroidal 5α-reductase, and, through interruption of testosterone conversion to 5α-dihydrotestosterone, can be efficient medicines for androgen-dependent syndromes, i.e. benign prostatic hyperplasia and prostate cancer, acne or male pattern baldness [7]. Research on oxidative metabolism of 3β-hydroxy-5-ene steroids has only sped up in the recent years.

Although steroidal BVMO activity was found in many fungi, only two enzymes from bacteria and lower eukaryotes have been characterized until now [8, 9] and whole-cell transformation processes are still the method of choice. Genome of a strain Penicillium lanosocoeruleum ATCC 48919, closely related to the one used in the current study, has been sequenced in the framework of the US Department of Energy Joint Genome Institute studies. Numerous enzymes possibly involved in steroid metabolism in this strain include, among others, 214 putative monooxygenases (however, no BVMOs), 27 putative steroid reductases (including three 3-ketosteroid reductases). The function of these proteins was however assigned only by sequence similarity to fungal enzymes of other species. We are not aware of any report linking the sequence information with enzymatic activity of P. lanosocoeruleum towards steroids. In light of the large number of possibly involved enzymes that cannot be readily isolated, we have rather adopted the strategy of considering the fungal cell as a micro-bioreactor, and we concentrated on the ability of a given strain to carry out successful biotransformation.

The ability to oxidize ketosteroids to lactones was detected in fungi of different taxonomic classes, especially: Aspergillus [1013], Fusarium [14, 15] and Penicillium [1622]. In many transformations, the formation of lactones from 3β-hydroxy-5-ene steroids was accompanied by modification of A-ring occurring through 3β-hydroxy-steroid dehydrogenase/5-ene-4-ene isomerase (3β-HSD) pathway.

Following the earlier reports [23], it was apparent that cleavage of the pregnane side chain involves four enzymatic reactions: BV oxidation of a substrate to its acetate, hydrolysis of the formed ester to alcohol which is then oxidized to ketone, and oxidative BV lactonization of this ketone to lactone. In transformation of progesterone to testololactone, Sebek and co-workers [16] have proposed a pathway including 20β-hydroxy-4-pregnen-3-one as an intermediate (Fig. 1). In a number of reports the 20-OH analogues of transformed substrates have been isolated [2426] and it has been suggested that there exists a competitive equilibrium between the reductase forming this alcohol and the oxidase that regenerates the C-20 ketone [16, 27, 28]. A similar relationship was observed in the oxidation of steroidal C-17 ketones by Beauveria bassiana [29, 30].
Fig. 1
Fig. 1

Metabolic pathway of side-chain cleavage of C21 steroids

Different microorganisms appeared to exhibit altered specificity with respect to the degradation of steroid side chain. For example, BVMOs from P. lilacinum [18], P. camembertii [19], P. simplicissimum [22], and F. oxysporum [15] were able to carry out the degradation of 17β-acetyl side chain of progesterone and pregnenolone, whereas BVMO from P. citreo-viride [17] and Beauveria bassiana [29] were inactive against pregnenolone. Scission at C17–C20 was observed in transformation of cortisone by A. parasiticus [13], but cortexolone was transformed to 20(R)-alcohol with no further transformation in A. tamarii KITA culture [25]. Interestingly, all the above mentioned microorganisms metabolized C-17 ketones to d-homo-lactones.

Previous studies carried out by our group demonstrated that P. lanosocoeruleum KCH 3012 metabolizes steroidal 5α-saturated, 4-ene and 5-ene C-17 ketones to the corresponding lactones [21]. In this microorganism steroidal 3β-HSD was active, and as a result dehydroepiandrosterone (DHEA) (a 3β-hydroxy-5-en steroid) was transformed exclusively to testololactone with 3-oxo-4-en functionality in A-ring. In order to explore more thoroughly the factors determining steroid metabolism by this organism, the current study was initiated to delineate the specificity of this microorganism with respect to the cleavage of steroid side chain of basic pregnenes—progesterone and pregnenolone. The effect of substituents at C-16 in pregnenolones (16-dehydropregnenolone, 16α-methoxy-pregnenolone and 16α,17α-epoxy-pregnenolone) on the course of this cleavage and on the general pattern of metabolic processing of these steroids was also investigated.

Results and discussion

Products isolated in the course of transformations

Biotransformation of progesterone (1)

After 72 h of reaction, the substrate was consumed and a single product was isolated. It was testololactone (4) (118 mg; 82% mol): 1H NMR (300 MHz, CDCl3) δH: 1.16 (3H, s, 19-H), 1.35 (3H, s, 18-H), 5.75 (1H, s, 4-H); 13C NMR (75 MHz, CDCl3): 17.4 (C-19), 19.9 (C-15), 20.1 (C-18), 21.9 (C-11), 28.6 (C-16), 30.5 (C-7), 32.4 (C-6), 33.8 (C-2), 35.5 (C-1), 38.0 (C-8), 38.4 (C-10), 39.1 (C-12), 45.7 (C-14), 52.5 (C-9), 82.7 (C-13), 124.1 (C-4), 169.2 (C-5), 171.1 (C-17), 199.2 (C-3). The spectroscopic data are in agreement with those reported in literature [18].

Biotransformation of pregnenolone (5)

After 96 h of fermentation, the following compounds were isolated (% mol): 79 mg (25%) of unreacted pregnenolone (5), 40 mg (28%) of testololactone (4), and 21 mg of the non-steroidal substance which was identified as (S)-curvularin (19): colorless crystals, [α] D 20  − 32.1 (c = 1.8 EtOH) (ref.: [α] D 20  − 33.0 (c = 2.0 EtOH) [31]); Rt = 3.62 min.; 1H NMR (300 MHz, CD3OD) δH: 1.16 (3H, d, J = 6.3 Hz, 17-CH3), 2.70–2.79 (1H, m, 3-Ha); 3.16–3.25 (1H, m, 3-Hb), 3.65 (1H, d, J = 15.6 Hz, 11-Ha), 3.86 (1H, d, J = 15.6 Hz, 11-Hb), 4.87–4.97 (1H, m, 8-H), 6.22 (1H, d, J = 2.4 Hz, 13-H), 6.25 (1H, d, J = 2.4 Hz, 15-H); 13C NMR (75 MHz, CD3OD): 20.4 (C-17), 23.8 (C-4), 24.9 (C-6), 27.7 (C-5), 33.0 (C-7), 40.4 (C-11), 44.6 (C-3), 73.8 (C-8), 102.7 (C-15), 112.2 (C-13), 120.9 (C-1), 137.2 (C-12), 159.4 (C-14), 161.1 (C-16), 172.8 (C-10), 209.7 (C-2). The spectroscopic data corresponded to those described in literature [32]. The X-ray structure of the product, presented in Fig. 2, is identical with that reported for (S)-curvularin [31].
Fig. 2
Fig. 2

X-ray crystal structure of (S)-curvularin (19)

Biotransformation of 16-dehydro-pregnenolone (8)

After 48 h of fermentation, the following compounds were isolated (% mol): 22 mg (16%) of testololactone (4) and 106 mg (73%) of 3β-hydroxy-17a-oxa-d-homo-androst-5-en-17-one (7): 1H NMR (300 MHz, CDCl3) δH: 0.96 (3H, s, 19-H), 1.30 (3H, s, 18-H), 3.53 (1H, tt, J = 11.9 Hz, J = 5.0, 3α-H), 5.33 (1H, d, J = 4.8 Hz, 6-H), 13C NMR (75 MHz, CDCl3): 19.3 (C-19), 19.9 (C-15), 20.1 (C-18), 21.9 (C-11), 28.8 (C-16), 31.1 (C-8), 31.5 (C-7), 34.4 (C-2), 36.6 (C-10), 36.9 (C-1), 38.9 (C-12), 41.9 (C-4), 46.7 (C-14), 49.0 (C-9), 71.5 (C-3), 83.2 (C-13), 120.6 (C-6), 140.6 (C-5), 171.5 (C-17). The spectroscopic data are in agreement with those reported in literature [18].

Biotransformation of 16α,17α-epoxy-pregnenolone (9)

After 72 h of fermentation, the following compounds were isolated (% mol): 8 mg (5%) of unreacted substrate 9, 3β,16α-dihydroxy-17a-oxa-d-homo-androst-5-en-17-one (10) (36 mg, 24%), 1H NMR (300 MHz, CDCl3) δH: 0.97 (3H, s, 19-H), 1.36 (3H, s, 18-H), 3.53 (1H, tt, J = 11.4 Hz, J = 4.5, 3α-H), 4.46 (1H, dd, J = 10.6 Hz, J = 4.5, 16β-H), 5.35 (1H, dt, J = 5.2, J = 1.9 Hz, 6-H), 13C NMR (75 MHz, CDCl3): 19.2 (C-18), 19.3 (C-19), 21.9 (C-11), 30.6 (C-15), 30.8 (C-7), 31.4 (C-2), 35.2 (C-8), 36.5 (C-10), 36.8 (C-1), 39.0 (C-12), 41.8 (C-4), 46.5 (C-14), 48.6 (C-9), 64.6 (C-16), 71.4 (C-3), 85.1 (C-13), 120.5 (C-6), 140.5 (C-5), 175.2 (C-17); 16α-hydroxy-17a-oxa-d-homo-androst-4-en-3,17-dione (11) (62 mg, 41%), 1H NMR (300 MHz, CDCl3) δH: 1.16 (3H, s, 19-H), 1.39 (3H, s, 18-H), 4.46 (1H, dd, J = 10.7 Hz, J = 4.6, 16β-H), 5.75 (1H, 4-H), 13C NMR (75 MHz, CDCl3): 17.3 (C-19), 19.2 (C-18), 21.8 (C-11), 30.2 (C-15), 30.6 (C-7), 32.2 (C-6), 33.7 (C-2), 35.4 (C-1), 38.3 (C-10), 38.6 (C-8), 39.0 (C-12), 45.7 (C-14), 52.1 (C-9), 64.4 (C-16), 84.5 (C-13), 124.2 (C-4), 168.9 (C-5), 174.9 (C-17), 199.0 (C-3); 3β,16α-dihydroxy-17a-oxa-d-homo-5α-androstan-17-one (12) (8 mg, 5%), 1H NMR (300 MHz, CDCl3) δH: 0.77 (3H, s, 19-H), 1.34 (3H, s, 18-H), 3.58–3.63 (1H, m, 3α-H), 4.46 (1H, dd, J = 10.7 Hz, J = 4.6, 16β-H), 13C NMR (75 MHz, CDCl3): 12.1 (C-19), 19.3 (C-18), 22.0 (C-11), 28.2 (C-6), 30.4 (C-7), 30.7 (C-15), 31.2 (C-2), 35.4 (C-10), 36.7 (C-1), 37.7 (C-4), 38.6 (C-8), 39.4 (C-12), 44.1 (C-5), 46.4 (C-14), 52.7 (C-9), 64.6 (C-16), 71.0 (C-3), 85.4 (C-13), 175.3 (C-17), and 16α-hydroxy-17a-oxa-d-homo-5α-androstan-3,17-dione (13) (8 mg, 5%), 1H NMR (300 MHz, CDCl3) δH: 0.98 (3H, s, 19-H), 1.36 (3H, s, 18-H), 4.46 (1H, dd, J = 10.7 Hz, J = 4.6, 16β-H), 13C NMR (75 MHz, CDCl3): 11.3 (C-19), 19.3 (C-18), 22.1 (C-11), 28.4 (C-6), 30.1 (C-7), 30.7 (C-15), 35.5 (C-10), 37.9 (C-2), 38.1 (C-1), 38.5 (C-8), 39.2 (C-12), 44.2 (C-4), 45.8 (C-14), 46.2 (C-5), 52.2 (C-9), 64.5 (C-16), 85.1 (C-13), 175.1 (C-17), 211.1 (C-3).

Biotransformation of 16α-methoxy-pregnenolone (16)

After 72 h of fermentation, the following compounds were isolated (% mol): 16α-methoxy-progesterone (17) (124 mg, 72%) 1H NMR (300 MHz, CDCl3) δH: 0.66 (3H, s, 18-H), 1.17 (3H, s, 19-H), 2.18 (3H. s, 21-H), 2.54 (1H, d, J = 3.0 Hz, 17α-H), 3.20 (3H, s, OCH3), 4.32–4.37 (1H, m, 16β-H), 5.74 (1H, s, 4-H). 13C NMR (75 MHz, CDCl3): 14.6 (C-18), 17.3 (C-19), 20.7 (C-11), 31.7 (C-21), 31.9 (C-7), 32.6 (C-6), 33.9 (C-15), 33.9 (C-2), 35.1 (C-8), 35.6 (C-1), 38.5 (C-10), 38.6 (C-12), 44.3 (C-13), 53.4 (C-9), 53.6 (C-14), 57.2 (C-22); 71.4 (C-17), 81.3 (C-16), 124.0 (C-4), 170.5 (C-5), 199.3 (C-3), 207.9 (C-20), and (20R)-20-hydroxy-16α-methoxy-pregn-4-en-3-one (18) (26 mg, 15%), 1H NMR (300 MHz, CDCl3) δH: 0.72 (3H, s, 18-H), 1.18 (3H, s, 19-H), 1.21 (3H, d, J = 6.0 Hz, 21-H), 3.32 (3H, s, OCH3), 3.86–3.91 (2H, m, 16β-H, 20-H), 5.74 (1H, s, 4-H). 13C NMR (75 MHz, CDCl3): 13.7 (C-18), 17.3 (C-19), 20.3 (C-11), 23.1 (C-21), 30.6 (C-15), 31.8 (C-7), 32.7 (C-6), 33.9 (C-2), 34.9 (C-8), 35.6 (C-1), 38.4 (C-12), 38.5 (C-10), 42.0 (C-13), 53.1 (C-14), 53.6 (C-9), 57.0 (C-22), 64.6 (C-17), 69.6 (C-20), 86.6 (C-16), 124.0 (C-4), 170.8 (C-5), 199.4 (C-3).

Structural identification of metabolites

Transformation of progesterone (1), pregnenolone (5) and 16-dehydro-pregnenolone (8) yielded known products: testololactone (4) and 3β-hydroxy-17a-oxa-d-homo-androst-5-en-17-one (7) which were identified by comparison of their spectroscopic data with the literature values [18] and on the basis of identity of their Rt from GC and Rf from TLC with standards available in our laboratory. The determination of the structure of the other metabolites was based primarily on their NMR data (see Additional file 1 for the relevant spectra). Thus, all the metabolites of 16α,17α-epoxy-pregnenolone (9) were devoid of the side-chain methyl-ketone resonance signals in 1H NMR spectrum at δH 2.02 ppm (21-CH3) and in 13C NMR spectrum at δC 26.0 ppm (C-21) and δC 205.0 ppm (C-20). The absence of these signals fully supported the assumption that removal of the side-chain had occurred. A significant downfield shift in comparison with the substrate was observed for the 18-methyl resonance signals in the 1H NMR spectra of these products (from δH 1.01 ppm for 5 to δH 1.36 ppm for 9, δH 1.39 ppm for 10, δH 1.34 ppm for 11, and δH 1.36 ppm for 12). It was consistent with an oxygen atom insertion into the ring-D. This was supported by the 13C NMR spectra in which C-13 resonance signal had undergone a downfield shift of ca. 43 ppm (to δC 85.1 ppm for 10, to δC 84.5 ppm for 11, to δC 85.4 ppm for 12, and to δC 85.1 ppm for 13). The lactonization in the ring-D of these metabolites, via Baeyer–Villiger oxidation, was confirmed by the appearance of the signal at δC ca. 175 ppm (C-17). The epoxide 16β-proton (δH 3.67 ppm) was absent from the spectra of metabolites 1013 indicating epoxide opening. This was supported by a new signal present in the 1H NMR spectra of these metabolites at δH ca.4.46 ppm and in the 13C NMR spectra at δC ca.64.6 ppm which demonstrated the presence of a hydroxyl group. The multiplicity of this signal in 1H NMR spectra suggested that it belongs to a proton coupled with only two protons which is consistent with a presence of 16-hydroxyl group. The stereochemistry of this hydroxyl group was further supported by NOESY spectra which showed correlation between H-16β signal and C-18 methyl group and H-15β signals (δH 2.12 ppm for 10, δH 2.05 ppm for 11, δH 2.10 ppm for 12, and δH 2.05 ppm for 13). This data led to identification of 10 as 3β,16α-dihydroxy-17a-oxa-d-homo-androst-5-en-17-one. The absence of the 3α-H resonance (tt) from the 1H NMR spectrum of the metabolite 11 coupled with an increase in the C-19 methyl resonance signal (Δ 0.12 ppm relative to the substrate 9) and a shift of the signal of the olefinic proton from δH 5.32 ppm to δH 5.75 ppm indicated double bond migration into ring A (between C-4 and C-5) and oxidation of the C-3 alcohol to a ketone. Oxidation of the 3β-OH group was fully supported by the loss of a methine signal at δC 74.6 ppm in the starting material 13C NMR spectrum, being replaced by a new non-protonated signal in the spectrum of the product at δC 199.0 ppm. Thus, the structure of metabolite 11 was deduced to be 16α-hydroxy-17a-oxa-d-homo-androst-4-en-3,17-dione. The NMR spectra of product 12 revealed that there were two hydroxyl groups (multiplet at δH 3.58–3.63 ppm and doublet of doublets at 4.46 ppm) and no carbon–carbon double bond. In comparison to the 13C NMR spectrum of 10, the disappearance of resonance signal at δC 120.5 ppm and δC 140.5 ppm confirmed hydrogenation of this double bond. This was further supported by a new presence of methine C-5 and methylene C-6 signals at δC 44.1 ppm and δC 28.2 ppm, respectively. Hydrogenation resulting in 5α-stereochemistry at A/B rings was determined by chemical shift of C-19 methyl group signal, which was resonating at similar field (δC 12.1 ppm and δH 0.77 ppm) when compared with known 3β-hydroxy-17a-oxa-d-homo-5α-androstan-17-one [21]. Therefore, the metabolite 12 was proposed to be 3β,16α-dihydroxy-17a-oxa-d-homo-5α-androstan-17-one. The 13C NMR spectrum of 13 was similar to that of 12 with the exception of signals of the A-ring carbons. The absence of the C-3 methine signal at δC 71.0 ppm and the appearance an additional quaternary carbon signal at δC 211.1 ppm indicated the oxidation of the C-3 hydroxyl to a carbonyl group. Also, the signal of 3α-proton disappeared in the 1H NMR spectrum and the chemical shift of C-19 methyl group signal was resonating at similar field (0.98 ppm) when compared with known 17a-oxa-d-homo-5α-androstan-3,17-dione [21]. This data led to the identification of 13 as 16α-hydroxy-17a-d-homo-5α-androstan-3,17-dione.

The resonance signals in both 1H and 13C NMR spectra of 17 and 18 suggested changes in the ring A and B of these molecules with respect to the substrate 16. The absence of the 3α-H multiplet at δH 3.52 ppm and a downfield shift signal of olefinic proton from δH 5.34 ppm to δH 5.74 ppm indicated isomerization of the double bond with its formation between C-4 and C-5 and oxidation of the C-3 alcohol to a ketone. Oxidation of the 3β-OH group was fully supported by the appearance of a new non-protonated signal at δC ca. 199 ppm. Its position was consistent with the position of a β-carbon conjugated with the carbonyl group. All these observations confirm the formation of 3-oxo-4-en moiety in the obtained products. Thus, metabolite 17 was identified as 16α-methoxyprogesterone. Evidence for identification of (20R)-20-hydroxy-16α-methoxy-pregn-4-en-3-one (18) was provided by the 13C NMR spectrum with loss of the resonance signal at δC 207.9 ppm for the C-20 ketone and its replacement with a HCOH signal at δC 69.6 ppm. Also, the C-21-methyl signal of 18 underwent an upfield shift (Δ 8.6 ppm) accordingly to the presence of the less electronegative alcohol, and the multiplet visible at δH 3.89 ppm showed correlation with the carbon C-20 in HSQC spectrum. Additional confirmation of C-20 reduction was the upfield shift (Δ 6.8 ppm) of resonance for C-17. This was coupled with the significant upfield shift (Δ 0.46 ppm) of the 16β-H resonance signal in 1H NMR spectrum, and NOESY spectrum showed correlation of 16α-OCH3 signal with the proton signal of C-20.

The structure of the non-steroidal compound 19 was determined by 2D NMR experiments and supported by the single crystal X-ray analysis (Fig. 2), which yielded a structure identical with a previous report [31]. The physical data, in particular optical rotation value of 19 were in agreement with those of (S)-curvularin published previously [31, 32].

The results herein presented clearly show that enzymes of P. lanosocoeruleum KCH 3012 are involved in the degradation of the C-17β-acetyl side chain of progesterone (1), pregnenolone (5), 16-dehydro- (8) and 16α,17α-epoxy-pregnenolone (9) via oxygenative esterification of these 20-ketosteroids and hydrolyze esters into alcohols and acetic acid. The subsequently formed 17-keto steroids could be then oxygenated by the lactonizing enzyme to their respective lactones (Fig. 3). Especially, for progesterone (1) the multistep transformation led to afford testololactone (4) as a single product isolated with 82% yield. The same metabolite (although with almost three times lower yield) was obtained from pregnenolone (5) and, as a minor metabolite, from 16-dehydro-pregnenolone (8). The main product of the conversion of 8 was lactone with conserved ring-A of the substrate—3β-hydroxy-17a-oxa-d-homo-androst-5-en-17-one (7).
Fig. 3
Fig. 3

Metabolites isolated following transformation of progesterone (1), pregnenolone (5), 16-dehydro-pregnenolone (8) and 16α,17α-epoxy-pregnenolone (9) by P. lanosocoeruleum

In order to investigate metabolic pathways of these two structurally related compounds (5 and 8), we studied composition of mixtures sampled after various transformation periods (Table 1). Their analysis indicated that the first stage of the transformation of pregnenolone (5) was the oxidative conversion its 3β-hydroxy-5-ene group to 3-oxo-4-ene system which resulted in progesterone (1), the product of its 17β-acetyl chain cleavage—testosterone (2), and its subsequent oxidation—androstenedione (3). Since the moment of identification this 3-oxo-4-ene C19 metabolites, the content of testololactone (4)—product of BV oxidation of C-17 ketone significantly increased reaching a maximum at 72 h of the process. Only small amount of DHEA (6) and 3β-hydroxy-lactone (7) were identified in the reaction mixtures even if the substrate 5 was present throughout the studied period of transformation.
Table 1

The time course of the transformation of progesterone, pregnenolone and 16-dehydropregnenolone by P. lanosocoeruleum

Substrate

Rt (min)

Steroidal compounds identified in the mixture (%)a

Time of transformation (h)

9

24

48

72

96

Progesterone (1)

6.82

Progesterone (1)

67

18

6

2

 

4.76

Testosterone (2)b

26

36

3

 

4.54

Androstenedione (3)b

7

10

5

2

 

8.69

Testololactone (4)

36

85

88

 

Pregnenolone (5)

5.57

Pregnenolone (5)

75

54

34

28

19

6.82

Progesterone (1)b

5

2

3

4

2

4.76

Testosterone (2)b

11

13

5

6

4.54

Androstenedione (3)b

4

3

8

3

3

3.51

DHEA (6)b

3

4

2

6.91

3β-Hydroxy-17a-oxa-d-homo-androst-5-en-17-one (7)b

2

6

8

5

8.69

Testololactone (4)

2

19

41

44

31

16-Dehydropregnenolone (8)

5.22

16-Dehydropregnenolone (8)

84

12

 

6.91

3β-Hydroxy-17a-oxa-d-homo-androst-5-en-17-one (7)

10

75

81

70

 

8.69

Testololactone (4)

5

13

18

30

 

aDetermined by GC analysis of the crude chloroform extracts

bIdentified in GC and TLC on the basis of standard

The products of scission of 17β-acetyl group—DHEA and androstenedione were not identified during the transformation of 16-dehydropregnenolone (8). Comparison of the course of transformation of both C21-20-ketones 5 and 8 in time indicated that 16-dehydro-analog of pregnenolone underwent conversion noticeably faster. Approximately 90% of the incubated 8 was affected by the enzymatic action of the fungus during first 24 h of transformation (Table 1). These reactions were mainly related to the ring-D of molecule. Thus, the oxidation in D-ring of 8 led to enol acetate which could then be rapidly hydrolyzed by an esterase, subsequently undergo rapid non-enzymatic rearrangement to DHEA and further oxidation to the respective lactone (Fig. 4). However, the final metabolites of 16(17)-dehydropregnenolone (8) were both lactones—3β-hydroxy-5-ene as well as 3-oxo-4-ene lactone (respectively, 7 and 4) (Fig. 4). The mixture after 24 h incubation of 8 contained larger percentage of hydroxylactone 7 than testololactone (4), whereas after transformation completion the amount of 4 was only twofold lower. Because at the same time the substrate 8 was not identified in the extracts, lactone 4 could be formed only via the conversion of hydroxylactone 7 (3β-HSD activity occurred following d-lactonization).
Fig. 4
Fig. 4

The possible metabolic pathway of 16-dehydro-pregnenolone (8) in P. lanosocoeruleum

When 16α,17α-epoxy-pregnenolone (9) was incubated with P. lanosocoeruleum we obtained mixture of four hydroxylactones. The substrate underwent a rare epoxide opening [25, 3335] resulting in retention of alpha stereochemistry to give 16α-hydroxy metabolites 1013 (Fig. 3). The proposed mechanism of this transformations is outlined in Fig. 5: cleavage at C17–C20 bond gives 16α-hydroxy-17-ketone which is subsequently converted via Baeyer–Villiger oxidation to 3β,16α-dihydroxy-17a-oxa-d-homo-androst-5-en-17-one (10). Other metabolites of 9 were mostly products of further transformations of this 16α-hydroxylactone. The observed reactions included the oxidation of hydroxyl group at C-3 to ketone and the subsequent isomerization of double bond C=C from C-5 to C-4 and hydrogenation of C5–C6 double bond. The time experiments indicated that the relative content of 10 was decreasing and 16α-hydroxy-17a-oxa-d-homo-androst-4-en-3,17-dione (11) began to dominate in the mixture of metabolites after 72 h of transformation (Table 2). Neither 16α,17α-epoxyprogesterone (14) nor 16α-hydroxyandrostenedione (15) were identified in any of the reaction mixtures, which suggests that 3β-HSD activity occurred here following ring d-lactonization. This is in contrast to previous studies in which 3β-HSD was active in the presence of a C-17 ketone as in DHEA [21] or a C-17 side chain such as pregnenolone (5). It is also interesting to note that the minor metabolites of 9 were 5α-saturated 16α-hydroxylactones (12 and 13). Although microbial hydrogenation of 4-en-3-keto steroids to 5-dihydrosteroids using Penicillium species has been described [12, 36], there is only one report for the reduction of C5-C6 double bond in ring B in 3β-hydroxy steroids [20].
Fig. 5
Fig. 5

The possible metabolic pathway of 16α,17α-epoxy-pregnenolone (9) by P. lanosocoeruleum

Table 2

The time course of the transformation of 16α,17α-epoxy-pregnenolone and 16α-methoxy-pregnenolone by P. lanosocoeruleum

Substrate

Rt (min.)

Steroidal compounds identified in the mixture (%)a

Time of transformation (h)

12

24

48

72

16α,17α-Epoxy-pregnenolone (9)

6.38

16α,17α-Epoxy-pregnenolone (9)

100

93

19

7

8.30

3β,16α-Dihydroxy-17a-oxa-d-homo-androst-5-en-17-one (10)

2

22

26

8.59

16α-Hydroxy-17a-oxa-d-homo-androst-4-en-3,17-dione (11)

1.5

31

48

9.06

3β,16α-Dihydroxy-17a-oxa-d-homo-5α-androstan-17-one (12)

1

7

8

9.86

16α-Hydroxy-17a-oxa-d-homo-5α-androstan-3,17-dione (13)

0.5

5

8

7.63

16α,17α-Epoxy-progesterone (14)b

6.96

16α-Hydroxyandrostenedione (15)b

16α-Methoxy-pregnenolone (16)

6.23

16α-Methoxy-pregnenolone (16)

33

8

1

7.65

16α-Methoxy-progesterone (17)

66

86

87

79

8.13

(20R)-20-Hydroxy-16α-methoxy-pregn-4-en-3-one (18)

1

4

12

19

aDetermined by GC analysis of the crude chloroform extracts

bIdentified in GC and TLC on the basis of standards

Incubation of 16α-methoxy-pregnenolone (16) resulted in a significantly different pattern of metabolism in comparison to other tested C21-20-ketones, notably being devoid of side chain degradation (Fig. 6). During the initial period of incubation of 16 the only identifiable metabolite was product of oxidation in A-ring—16α-methoxy-progesterone (17). The mixture after 12 h of reaction contained 66% of 17 and it was the highest content of 3-oxo-4-ene metabolite of tested 3β-hydroxy-5-ene steroids. Some amount of this derivative in the next hours was reduced to (20R)-20-hydroxy-16α-methoxy-pregn-4-en-3-one (18), whose content at the end of the transformation reached only 19%. The stereochemical reduction at C-20 of pregnanes is common to a wide range of fungi [3] and often precedes the reaction of side-chain cleavage to form androstane derivatives. Because the resulting (20R)-20-hydroxy-16α-methoxy-pregn-4-en-3-one (18) did not undergo further transformation, it can be assumed that in the presence of 16α-methoxy substituent the 20-hydroxy group could not be re-oxidized to the corresponding C-20 ketone and finally BVMO could not be activated. In this case it was probable that intramolecular hydrogen bonds may be inhibiting substrate binding to the oxidase. However, a physical ball-and-stick model demonstrated possibility of only a weak hydrogen interaction between the C-20 hydroxyl group and 16α-methoxy group (more than 3.2 Å), and this reason should be discarded. It is worth noting that we were unable to isolate the corresponding 20-alcohols from other tested steroids. This may indicate that progesterone (1) and pregnenolones 5, 8 and 9 do not activate reductase or that their molecular structure is precluding binding to this enzyme. On the other hand, the mentioned substrates were metabolized at a faster rate than 16 by side-chain degrading enzymes (Tables 1, 2) and therefore accumulation of 20-dihydro compounds was prevented.
Fig. 6
Fig. 6

Metabolites isolated following transformation of 16α-methoxy-pregnonolone (16) by P. lanosocoeruleum

During the experiments carried out to elucidate the pattern of metabolic processing of steroidal compounds by P. lanosocoeruleum KCH3012, we unexpectedly noticed that there may result activation of silent biosynthetic pathways for production of polyketide metabolites. From fermentation medium after 4 days transformation of pregnenolone (5) we isolated in large yield a 12-membered macrolactone—(S)-curvularin (19). Curvularin and its structural relatives are produced by a number of phytopatogenic fungi from such genera as Curvularia, Alternaria and Penicillium [37], but this is the first report of the occurrence of curvularin in the species P. lanosocoeruleum. It is apparent that further investigation is required and we hope to provide detailed information of this finding in future reports.

Conclusions

This work and previous studies with P. lanosocoeruleum KCH 3012 clearly demonstrated that this microorganism has potent multi-functional catalytic properties towards androstane- and pregnane-type steroids. It contains (in similarity to P. lilacinum AM111 [18], P. camembertii AM83 [19], P. simplicissimum WY134-2 [22]) an endogenous lactonization pathway which can transform progesterone to testololactone with high yield. In this microorganism a steroidal 3β-HSD was active, and as a result the same metabolite (although with lower yield) was obtained from pregnenolone. This is in contrast to the result with P. citreo-viride ACCC 0402 where pregnenolone was not transformed [17] or with P. lilacinum AM111 which oxidized pregnenolone to 3β-hydroxy-17a-oxa-d-homo-androst-5-en-17-one—a d-lactone with conserved 5-en-3β-OH moiety [18]. The tested microorganism was able to attack side chains of steroids bearing substituents at C-16. Moreover, studies have highlighted that a slight modification of the D-ring of the substrate may induce and control metabolic fate either into the lactonization or reductive and oxidative pathways. The presence of double bond at C-16 appears to stimulate the rate of metabolism in the D-ring, and as consequence, the transformation of 16-dehydropregnenolone yields 3β-hydroxy-5-ene D-lactone. Importantly, our studies have demonstrated for the first time that incubation of 16α,17α-epoxy-pregnenolone with a fungus strain belonging to the genus Penicillium resulted in a mixture of 16α-hydroxy lactones. Possibility of epoxide opening by enzymes from this fungus affords a unique opportunity for generation of novel bioactive steroidal compounds. Furthermore, we showed that no steroidal lactone was formed after transformation of 16α-methoxy-pregnenolone. This would suggest that the presence of the 16α-methoxy group prevents the side chain cleavage in C21 steroids.

Methods

Materials

Progesterone (1), pregnenolone (5), 16α,17α-epoxy-pregnenolone (9), 16α,17α-epoxy-progesterone (14), and 16-dehydropregnenolone acetate (20) were purchased from Sigma-Aldrich Chemical Co. Testosterone (2), androstenedione (3), DHEA (dehydroepiandrosterone) (6) were purchased from Steraloids Inc. 16α-Hydroxyandrostenedione (15) was obtained in our previous work by transformation of testosterone using Aspergillus niger KCH910 [38]. The last four of the aforementioned compounds and 14 were used as analytical standards for the time course experiments. 16-Dehydro-pregnenolone (8) and 16α-methoxy-pregnenolone (16) (in a ratio of 3:7) were prepared from the 16-dehydropregnenolone acetate (20) by its saponification with potassium hydroxide in methanol [39]. The resulting mixture was chromatographed on a column of silica with cyclohexane/chloroform/diethyl ether (1:0.75:1 v/v/v) as eluent. The products were found to be in excess of 98.5 and 97.2% purity following GC analysis.

16-Dehydro-pregnenolone (8)

1H NMR (300 MHz, CDCl3) δH: 0.90 (3H, s, 18-H), 1.03 (3H, s, 19-H), 2.25 (3H. s, 21-H), 3.52 (1H, m, 3α-H), 5.35 (1H, d, J = 4.3 Hz, 6-H), 6.70 (1H, s, 16-H). 13C NMR (75 MHz, CDCl3): 15.7 (C-18), 19.3 (C-19), 20.7 (C-11), 27.1 (C-21), 30.2 (C-8), 31.5 (C-7), 31.6 (C-2), 32.2 (C-15), 34.6 (C-12), 36.7 (C-10), 37.1 (C-1), 42.2 (C-4); 46.1 (C-13); 50.4 (C-9), 56.4 (C-14), 71.7 (C-3), 121.1 (C-6), 141.3 (C-5), 144.5 (C-16), 155.6 (C-17), 196.9 (C-20). NMR data was found to be in good agreement with that described by Szendi [40].

16α-Methoxy-pregnenolone (16)

1H NMR (300 MHz, CDCl3) δH: 0.62 (3H. s, 18-H), 0.99 (3H, s, 19-H), 2.17 (3H. s, 21-H), 2.53 (1H, d, J = 3.0 Hz, 17α-H), 3.20 (1H, s, 16α-OCH3), 3.50–3.54 (1H, m, 3α-H), 4.33–4.35 (1H, m, 16β-H), 5.34 (1H, d, J = 2.7 Hz, 6-H). 13C NMR (75 MHz, CDCl3): 14.4 (C-18), 19.3 (C-19), 20.7 (C-11), 31.4 (C-8), 31.5 (C-2, C-15), 31.7 (C-21), 31.9 (C-7), 36.5 (C-10), 37.1 (C-1), 38.8 (C-12), 42.2 (C-4), 44.4 (C-13), 49.8 (C-9), 54.4 (C-14), 57.1 (C-22), 71.6 (C-3, C-17), 81.4 (C-16), 121.2 (C-6), 140.7 (C-5), 208.1 (C-20). NMR data was found to be identical with that given by Wölfling [41].

The fungal strain Penicillium lanosocoeruleum KCH 3012 used in this study was taken from the collection of the Department of Chemistry, Wrocław University of Environmental and Life Sciences (Wrocław, Poland). The fungus was maintained on Sabouraud 4% dextrose-agar slopes at 4 °C and freshly subcultured before use in the transformation experiments.

General conditions of cultivation and transformation

General experimental and fermentation details were described previously [18]. Each substrate was added to a 72-h-old culture of the microorganism as an acetone solution, in concentration of 0.16 mmol/100 mL of medium, and incubated for 3–4 days (until the contents of the substrate in the reaction mixture reached stationary level) at 25 °C in a rotary shaker (180 rpm). Each experiment was performed with three replications.

Isolation and identification of the products

The products of biotransformation were extracted three times with ethyl acetate. The organic extracts were dried over anhydrous magnesium sulfate, concentrated in vacuo and analyzed by TLC and GC. Transformation products were separated by column chromatography on silica gel with ethyl acetate:methylene chloride:acetone (3:1:1 v:v:v) for progesterone (1) and pregnonolone (5), hexane:ethyl acetate:isopropyl alcohol (2:0.5:0.5 v:v:v) for 16-dehydro-pregnenolone (8), ethyl acetate:diethyl ether (2:1 v:v) for 16α,17α-epoxypregnenolone (9), or hexane:ethyl acetate:isopropyl alcohol (1:0.15:0.1 v:v:v) for 16α-methoxy-pregnenolone (16) as eluents. TLC was carried out with Kieselgel 60 F254 plates (Merck, Darmstadt, Germany) using the same eluents. In order to develop the image, the plates were sprayed with solution of methanol in concentrated sulfuric acid (1:1) and heated to 120 °C for 3 min. GC analysis was performed using Hewlett Packard 5890A Series II GC instrument (FID, carrier gas H2 at flow rate of 2 mL min−1) with DB-5MS column cross-linked phenyl-methylsiloxane, 30 m × 0.32 mm × 0.25 μm film thickness. The following program was used in the GC analysis: 220 °C/1 min, gradient 4 °C/min to 280° and 30 °C/min to 300°/2 min (for 1, 5 and 8) or 230 °C/1 min, gradient 4 °C/min to 280° and 30 °C/min to 300°/2 min (for 9 and 16); injector and detector temperatures were 300 °C. The NMR spectra were measured in CDCl3 or CD3OD and recorded on a DRX 300 MHz Bruker Avance spectrometer. Characteristic 1H- and 13C-NMR shift values in comparison to the starting compounds were used to determine structures of metabolites, in combination with DEPT analysis to identify the nature of the carbon atoms. Optical rotation measurements were carried out on Autopol IV automatic polarimeter (Rudolph).

Time course experiments

For studying the time-dependent progress of the bioconversion and to determine the metabolic pathways of substrates, 5-mL samples of the broth were taken out at regular intervals from the reaction flask, extracted with ethyl acetate and analyzed by comparison of the GC and TLC data with those of authentic samples. Conditions of the reaction were identical to those in the main biotransformation experiments.

Declarations

Authors’ contributions

AŚ and AP conceived and designed the research. AŚ, AP and PO performed the experiments, AŚ and AP analyzed and interpreted the data. AŚ and AP wrote the paper. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated during this study are included in this published article and its Additional file.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This project and publication were supported by Wrocław Centre of Biotechnology, The Leading National Research Centre (KNOW) Program for years 2014–2018.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Chemistry, Wrocław University of Environmental and Life Sciences, Norwida, 25, 50-375 Wrocław, Poland

References

  1. Nassiri-Koopaei N, Faramarzi MA. Recent developments in the fungal transformation of steroids. Biocatal Biotransform. 2015;33:1–28.View ArticleGoogle Scholar
  2. Świzdor A, Kołek T, Panek A, Milecka N. Selective modification of steroids performed by oxidative enzymes. Curr Org Chem. 2012;16:2551–82.View ArticleGoogle Scholar
  3. Bhatti HN, Khera RA. Biological transformation of steroidal compounds: a review. Steroids. 2012;77:1267–90.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Peterson DH, Eppstein SH, Meister PD, Murray HC, Leigh HM, Weintraub A, Reineke LM. Microbiological transformations of steroids. IX. Degradation of C21 to C19 ketones and to testololactone. J Am Chem Soc. 1953;75:5768–9.View ArticleGoogle Scholar
  5. Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD. Natural products as aromatase inhibitors. Anticancer Agents Med Chem. 2008;8:646–82.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Eugster EA. Aromatase inhibitors in precocious puberty: rationale and experience to date. Treat Endocrinol. 2004;3:141–51.View ArticleGoogle Scholar
  7. Garrido M, Bratoeff E, Bonilla D, Soriano J, Heuze Y, Cabeza M. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor. J Steroid Biochem Mol Biol. 2011;127:367–73.View ArticleGoogle Scholar
  8. Itagaki E. Studies on steroid monooxygenase from Cylindrocarpon radicicola ATCC 11011. Oxigenative lactonization of androstenedione to testololactone. J Biochem. 1986;99:825–32.View ArticleGoogle Scholar
  9. Morii S, Sawamoto S, Yamauchi Y, Miyamoto M, Iwami M, Itagaki E. Steroid monooxygenase of Rhodococcus rhodochrous: sequencing of the genomie DNA, and hyperexpression, purification, and characterization of the recombinant enzyme. J Biochem. 1999;126:624–31.View ArticleGoogle Scholar
  10. Faramarzi MA, Yazdi MT, Amini M, Mohseni FA, Zarrini G, Amani A, Shafiee A. Microbial production of testosterone and testololactone in the culture of Aspergillus terreus. World J Microbiol Biotechnol. 2004;20:657–60.View ArticleGoogle Scholar
  11. Hunter AC, Elsom J, Ross L, Barrett R. Ring-B functionalized androst-4-en-3-ones and ring-C substituted pregn-4-en-3-ones undergo differential transformation in Aspergillus tamarii KITA: ring-A transformation with all C-6 substituted steroids and ring-D transformation with C-11 substituents. Biochim Biophys Acta. 2006;1761:360–6.View ArticleGoogle Scholar
  12. Yildirim K, Uzuner A, Gulcuoglu E. Biotransformation of some steroids by Aspergillus terreus MRC 200365. Collect Czechoslov Chem Commun. 2010;75:665–73.View ArticleGoogle Scholar
  13. Mascotti ML, Palazzolo MA, Bisogno FR, Kurina-Sanz M. Biotransformation of dehydro-epi-androsterone by Aspergillus parasiticus: metabolic evidences of BVMO activity. Steroids. 2016;109:44–9.View ArticleGoogle Scholar
  14. Čapek A, Hanč O. Microbiological transformation of steroids. XII. Transformation of steroids by different species and strains of Fusaria. Folia Microbiol. 1960;5:251–6.View ArticleGoogle Scholar
  15. Zhang H, Ren J, Wang Y, Sheng C, Wu Q, Diao A, Zhu D. Effective multi-step functional biotransformations of steroids by a newly isolated Fusarium oxysporum SC1301. Tetrahedron. 2013;69:184–9.View ArticleGoogle Scholar
  16. Sebek OK, Reineke LM, Peterson DH. Intermediates in the metabolism of steroids by Penicillium lilacinum. J Bacteriol. 1962;83:1327–31.PubMedPubMed CentralGoogle Scholar
  17. Liu H-M, Li H, Shan L, Wu J. Synthesis of steroidal lactones by Penicillium citreo-viride. Steroids. 2006;71:931–4.View ArticleGoogle Scholar
  18. Kołek T, Szpineter A, Świzdor A. Baeyer–Villiger oxidation of DHEA, pregnenolone, and androstenedione by Penicillium lilacinum AM111. Steroids. 2008;73:1441–5.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Kołek T, Szpineter A, Świzdor A. Studies on Baeyer–Villiger oxidation of steroids: DHEA and pregnenolone d-lactonization pathways in Penicillium camemberti AM83. Steroids. 2009;74:859–62.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Huang LH, Li J, Xu G, Zhang XH, Wang YG, Yin YL, Liu HM. Biotransformation of dehydroepiandrosterone (DHEA) with Penicillium griseopurpureum Smith and Penicillium glabrum (Wehmer) Westling. Steroids. 2010;75:1039–46.View ArticleGoogle Scholar
  21. Świzdor A. Baeyer–Villiger oxidation of some C19 steroids by Penicillium lanosocoeruleum. Molecules. 2013;18:13812–22.View ArticleGoogle Scholar
  22. Yang B, Wang Y, Chen X, Feng J, Wu Q, Zhu D, Ma Y. Biotransformations of steroids to testololactone by a multifunctional strain Penicillium simplicissimum WY134-2. Tetrahedron. 2014;70:41–6.View ArticleGoogle Scholar
  23. Rahim MA, Sih CJ. Mechanisms of steroid oxidation by microorganisms. XI. Enzymatic cleavage of the pregnane side chain. J Biol Chem. 1966;241:3615–23.Google Scholar
  24. Faramarzi MA, Yazdi MT, Sfafiee A, Zarrini G. Microbial transformation of hydrocortisone by Acremonium strictum PTCC 5282. Steroids. 2001;67:869–72.View ArticleGoogle Scholar
  25. Hunter AC, Carragher NE. Flexibility of the endogenous progesterone lactonisation pathway in Aspergillus tamarii KITA: transformation of a series of cortical analogues. J Steroid Biochem Mol Biol. 2003;87:301–8.View ArticleGoogle Scholar
  26. Peart PC, McCook KP, Russell FA, Reynolds WF, Reese PB. Hydroxylation of steroids by Fusarium oxysporum, Exophiala jeanselmei, and Ceratocystis paradoxa. Steroids. 2011;76:1317–30.View ArticleGoogle Scholar
  27. Brannon DR, Parrish FW, Wiley BJ, Long L Jr. Microbial transformation of a series of androgens with Aspergillus tamarii. J Org Chem. 1967;32:1521–7.View ArticleGoogle Scholar
  28. Carlström K. Side chain degradation of epimeric 20-hydroxy-4-pregnene-3-ones by Penicillium lilacinum NRRL 895. Acta Chem Scand. 1970;24:1759–67.View ArticleGoogle Scholar
  29. Świzdor A, Kołek T, Panek A, Białońska A. Microbial Baeyer–Villiger oxidation of steroidal ketones using Beauveria bassiana: presence of an 11α-hydroxyl group essential to generation of d-homo lactones. Biochim Biophys Acta-Mol Cell Biol Lipids. 2011;1811:253–62.View ArticleGoogle Scholar
  30. Świzdor A, Panek A, Milecka-Tronina N. Microbial Baeyer–Villiger oxidation of 5α-steroids using Beauveria bassiana. A stereochemical requirement for the 11α-hydroxylation and the lactonization pathway. Steroids. 2014;82:44–52.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Elzner S, Schmidt D, Schollmeyer D, Erkel G, Anke T, Kleinert H, Förstermann U, Kunz H. Inhibitors of inducible NO synthase expression: total synthesis of (S)-curvularin and its ring homologues. ChemMedChem. 2008;3:924–39.View ArticleGoogle Scholar
  32. Kumar CG, Mongolla P, Sujitha P, Joseph J, Babu KS, Suresh G, Ramakrishna KVS, Purushotham U, Sastry GN, Kamal A. Metabolite profiling and biological activities of bioactive compounds produced by Chrysosporium lobatum strain BK-3 isolated from Kaziranga National Park, Assam, India. SpringerPlus. 2013;2:122.View ArticlePubMedPubMed CentralGoogle Scholar
  33. El-Tayeb O, Knight SG, Sih CJ. Steroid epoxide cleavage by Cylindrocarpon radicicola. Biochim Biophys Acta. 1964;93:402–10.View ArticleGoogle Scholar
  34. Ge W, Wang S, Shan L, Li N, Liu H. Transformation of 3β-hydroxy-5-en steroids by Mucor racemosus. J Mol Catal B Enzym. 2008;55:37–42.View ArticleGoogle Scholar
  35. Hunter AC, Coyle E, Morse F, Dedi C, Dodd HT, Koussoroplis SJ. Transformation of 5-ene steroids by the fungus Aspergillus tamarii KITA: mixed molecular fate in lactonization and hydroxylation pathways with identification of a putative 3β-hydroxy-steroid dehydrogenase/Δ5−Δ4 isomerase pathway. Biochim Biophys Acta. 2009;1791:110–7.View ArticleGoogle Scholar
  36. Cabeza MS, Gutiérrez EB, García GA, Avalos AH. Hernández MAH. Microbial transformations of testosterone to 5α-dihydrotestosterone by two species of Penicillium: P. chrysogenum and P. crustosum. Steroids. 1998;64:379–84.View ArticleGoogle Scholar
  37. de Castro MV, Ióca LP, Williams DE, Costa BZ, Mizunom CM, Santos MF, de Jesus K, Fetteira EVL, Seleghim MH, Sette LD. Condensation of macrocyclic polyketides produced by Penicillum sp, DRF2 with mercaptopyruvate represents a new fungal detoxification pathway. J Nat Prod. 2016;79:1668–78.View ArticleGoogle Scholar
  38. Świzdor A, Panek A, Milecka-Tronina N. Hydroxylative activity of Aspergillus niger towards androst-4-ene and androst-5-ene steroids. Steroids. 2017;126:101–6.View ArticleGoogle Scholar
  39. Gould D, Gruen F, Hershberg EB. 16α-Methoxy-5-pregnen-3β-ol-20-on. J Am Chem Soc. 1953;75:2510–1.View ArticleGoogle Scholar
  40. Szendi Z, Forgό P, Sweet F. Complete 1H and 13C NMR spectra of pregnenolone. Steroids. 1995;60:442–6.View ArticleGoogle Scholar
  41. Wölfling J, Magyar A, Schneider G. Synthesis of novel d-seco-pregnenes. Monatsch Chem. 2003;134:1387–93.Google Scholar

Copyright

© The Author(s) 2018

Advertisement